scholarly journals PHARMACOKINETICS AND ANALGESIC EFFECT OF SLOW-RELEASE ORAL MORPHINE SULPHATE IN VOLUNTEERS

1984 ◽  
Vol 56 (8) ◽  
pp. 821-827 ◽  
Author(s):  
M. VATER ◽  
G. SMITH ◽  
G.W. AHERNE ◽  
A.R. AITKENHEAD
1989 ◽  
Vol 27 (18) ◽  
pp. 71-72

Oral morphine is the standard analgesic for severe opioid-responsive cancer pain.1 It is traditionally used as an aqueous solution, prepared as needed by the hospital or community pharmacy, and although slow-release morphine sulphate tablets (MST-Continus) are now widely used many doctors still prescribe an aqueous solution for initial dose titration, for top-up use, “as needed” use and for patients who dislike tablets.2


2012 ◽  
Author(s):  
Marica Ferri ◽  
Silvia Minozzi ◽  
Laura Amato ◽  
Alessandra Bo ◽  
Marina Davoli

1972 ◽  
Vol 10 (10) ◽  
pp. 40-40

Depronal SA is a slow-release formulation of dextropropoxyphene,1 a synthetic non-narcotic drug with about the same analgesic effect as codeine. The drug is available alone as 65 mg capsules (Doloxene) and also mixed with various other drugs, e.g. as Doloxene Co-65 (with aspirin, phenacetin and caffeine) and as Distalgesic (with paracetamol).


2019 ◽  
Vol 40 (4) ◽  
pp. 473-475 ◽  
Author(s):  
Gerrit Prinsloo ◽  
Keith Ahamad ◽  
M. Eugenia Socías

Sign in / Sign up

Export Citation Format

Share Document